Our expertise in biomaterials, micro-electro-mechanical systems (MEMS), microsystems and human factors enables higher-density electrical and optical interfaces that reduce surgical burden and improve reliability for chronic use.
Draper ASICs are discriminating technologies for ultra-miniature, low-power and high-performance applications—including low-noise sensing, precision stimulation, power management and high- bandwidth telemetry.
Draper’s expertise in microelectronics, dense packaging and advanced hermetic materials enables smaller devices with greater functionality. Our proprietary micro-hermetic packaging technology combines die-level sealing, high-density micro feedthroughs and micro-bonding to external leads.
Draper applies expertise in radio frequency (RF) simulations, novel antennas, mixed-signal ASIC design, data compression and secure communications to create next-generation wireless power and data solutions to support advances in bioelectronics.
We draw on expertise in micro-structures, materials, chemistry and advanced integrated circuit design to develop next-generation, solid-state batteries and high-efficiency power management solutions. Our advanced packaging technologies enable smaller and long-lasting devices.
To protect patient safety and data privacy and security, Draper develops security solutions to support next-generation wirelessly networked architectures and closed-loop systems. From component-level design to system-level architecture, we can accurately identify threats, assess vulnerabilities and develop layered solutions for end-to-end security and safety.
We engineer novel technologies for both wired and wireless networks of implantable and wearable devices. These networks support emerging closed-loop and distributed therapies based upon a systems- level view of disease.
Recent advancements include a miniature, wireless and networked neuromodulation system that is about 20 times smaller than existing implants. The system consists of tiny implantable devices, called Gemstones, that are the size of a kidney bean. Recorded biosignals can be monitored by distributed Gemstones and used to trigger coordinated stimulation therapies on-the-fly to target disease in ways not previously possible.